ArticleQuantitative imaging in medicine and surgery2025
Preoperative CT-based artificial intelligence-derived quantitative parameters and imaging features for predicting the invasiveness of histologically confirmed subcentimeter adenocarcinomatous nodules: a two-center study.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Super-resolution and habitat radiomics based computed tomography machine-learning model for prediction of lung invasive adenocarcinoma: a multi-centre study.Quantitative imaging in medicine and surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Assessing the invasiveness of subcentimeter pulmonary adenocarcinomas remains challenging. Computed tomography (CT) provides objective data, but radiologic interpretation is subjective. Artificial intelligence (AI)-derived quantitative parameters may offer a more reproducible assessment for small nodules. This study aimed to develop and validate models based on CT-derived AI quantitative parameters nodules and imaging features to predict the invasiveness of subcentimeter adenocarcinomatous nodules. Methods: Patients diagnosed with subcentimeter adenocarcinomatous nodules from two centers between January 2021 and December 2022 were retrospectively included, and their associated quantitative AI parameters and CT radiologic features were recorded and analyzed. Independent predictors associated with the invasiveness of subcentimeter adenocarcinomatous nodules were identified through univariate and multivariate logistic regression analyses. A qualitative model based on CT radiologic features (density, irregular morphology, and leaflet), a quantitative model based on AI-derived parameters (longest, entropy, and mass), and a combined model integrating both were subsequently constructed. The performance of the models was evaluated by calculating the area under the curve (AUC), sensitivity, specificity, positive predictive value, negative predictive value, accuracy and F-measure. Results: A total of 337 patients from Shanghai Changzheng Hospital and Kunshan Third People's Hospital were included in this study. Among the qualitative features, density, irregular morphology, and leaflet were identified as independent predictors of invasive lung cancer, and a qualitative model was constructed. Among the quantitative parameters, longest diameter, entropy, and mass were identified as independent predictors, and a quantitative model was developed accordingly. In the training set, the areas under the curve of the qualitative, quantitative, and combined models were 0.818, 0.849, and 0.901, respectively. Conclusions: In this cohort, models combining quantitative CT AI parameters with CT radiologic features demonstrated high performance in predicting the invasiveness of subcentimeter adenocarcinomatous nodules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.